127.29
price up icon0.87%   1.10
pre-market  プレマーケット:  127.21   -0.08   -0.06%
loading
前日終値:
$126.19
開ける:
$125.47
24時間の取引高:
5.45M
Relative Volume:
0.82
時価総額:
$221.46B
収益:
$43.11B
当期純損益:
$13.98B
株価収益率:
15.95
EPS:
7.98
ネットキャッシュフロー:
$6.78B
1週間 パフォーマンス:
+0.59%
1か月 パフォーマンス:
-6.58%
6か月 パフォーマンス:
-0.50%
1年 パフォーマンス:
+15.56%
1日の値動き範囲:
Value
$125.47
$127.77
1週間の範囲:
Value
$125.47
$129.70
52週間の値動き範囲:
Value
$107.11
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1163)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
114,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2025-07-17
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

ABT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
ABT
Abbott Laboratories
127.29 219.63B 43.11B 13.98B 6.78B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
105.41 155.22B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
377.79 150.09B 23.82B 2.92B 4.02B 7.55
Medical Devices icon
MDT
Medtronic Plc
89.34 115.62B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
79.33 46.52B 5.69B 4.15B 623.10M 6.95

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-18 アップグレード Jefferies Hold → Buy
2025-06-16 開始されました Leerink Partners Market Perform
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
Aug 03, 2025

Is it the right time to buy Abbott Laboratories stockTremendous wealth creation - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 03, 2025

When is Abbott Laboratories stock expected to show significant growthConsistent high-performance stocks - jammulinksnews.com

Aug 03, 2025
pulisher
Aug 02, 2025

RECKITT (RBGLY) URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Reckitt Benckiser Group plc and Encourages Investors to Contact the Firm - GlobeNewswire Inc.

Aug 02, 2025
pulisher
Aug 02, 2025

Abbott Laboratories Second Quarter 2025 Earnings: EPS Beats Expectations - simplywall.st

Aug 02, 2025
pulisher
Aug 01, 2025

Similac NEC Lawsuit: 2025 Updates & List of Affected Formulas - Drugwatch.com

Aug 01, 2025
pulisher
Aug 01, 2025

Stock Analysis | Abbott Laboratories OutlookMixed Signals Amid Analyst Optimism and Technical Neutrality - AInvest

Aug 01, 2025
pulisher
Jul 31, 2025

Abbott Laboratories Shares Drop 1.84 as Analysts Clash on Value Amid $850M Volume 155th in Market Activity - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

How volatile is Abbott Laboratories stock compared to the marketMarket Forecast Signals For Fast Growth - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Why Abbott Laboratories (ABT) Remains a Buy Despite Diagnostic Segment Weakness - AInvest

Jul 31, 2025
pulisher
Jul 31, 2025

UBS Shrugs Abbott Laboratories’ (ABT) Diagnostic Weakness Affirms ‘Buy’ Rating - MSN

Jul 31, 2025
pulisher
Jul 30, 2025

Biotechnology Market is evolving rapidly Through 2025 To 2032 | Abbott Laboratories, Amgen Inc., GlaxoSmithKline - openPR.com

Jul 30, 2025
pulisher
Jul 30, 2025

Abbott Gains 1.31% Amid 140th Trading Volume Rank as Analysts Weigh Diagnostic Sector Growth and Competitive Risks - AInvest

Jul 30, 2025
pulisher
Jul 30, 2025

Meal Replacement Market Is Booming Worldwide 2025-2032 | Abbott - openPR.com

Jul 30, 2025
pulisher
Jul 29, 2025

Paul MacDonald's Top Picks: Stryker, Abbott Labs & Elevance Health - BNN Bloomberg

Jul 29, 2025
pulisher
Jul 29, 2025

Human Papilloma Virus Testing Market Research Report 2025-2033 Featuring Abbott Laboratories, BioMerieux, Bio-Rad Laboratories, Epigenomics, Siemens Healthineers, Hologic, Qiagen, F. Hoffmann-La Roche - Yahoo Finance

Jul 29, 2025
pulisher
Jul 29, 2025

RBC Capital Sees Strong Growth Potential for Abbott Laboratories (ABT) - MSN

Jul 29, 2025
pulisher
Jul 28, 2025

2nd Abbott Baby Formula Bellwether Falls Before Trial - Law360

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Abbott Laboratories stockMaximize your portfolio’s growth potential - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Does Abbott Laboratories stock perform well during market downturnsBuild a winning investment strategy today - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

RBC Capital gives Abbott Laboratories a thumbs-up, sees stock go higher. What's the best time to buy - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

Leerink Partners Decreases PT on Abbott Laboratories (ABT) to $136 From $143, Maintains a Hold Rating - Insider Monkey

Jul 28, 2025
pulisher
Jul 28, 2025

Abbott Laboratories' Q2 Earnings Report Presents Mixed Picture, Leerink Partners Decreases PT to $136, Maintains Hold Rating - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

RBC Capital Bullish on Abbott Laboratories, Raises Price Target to $147. - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

How does Abbott Laboratories generate profit in a changing economyMaximize your returns with portfolio optimization - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Why is Abbott Laboratories stock attracting strong analyst attentionBuild wealth with steady, reliable stocks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Declining Stock and Solid Fundamentals: Is The Market Wrong About Abbott Laboratories (NYSE:ABT)? - Yahoo Finance

Jul 27, 2025
pulisher
Jul 26, 2025

Continental Express wins fifth Abbott award - Sidney Daily News

Jul 26, 2025
pulisher
Jul 26, 2025

Did Strong Q2 Results and Raised Guidance Just Shift Abbott Laboratories' (ABT) Investment Narrative? - simplywall.st

Jul 26, 2025
pulisher
Jul 26, 2025

Oversold Abbott Laboratories (ABT) Could Offer a Healthy Dividend Opportunity - MSN

Jul 26, 2025
pulisher
Jul 25, 2025

What analysts say about Abbott Laboratories stockConsistent high-performance stocks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Abbott Laboratories Stock Analysis and ForecastDynamic growth stocks - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Abbott Laboratories stock priceOutstanding capital appreciation - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Abbott Laboratories (ABT): A Bull Case Theory - MSN

Jul 24, 2025
pulisher
Jul 24, 2025

The Zacks Analyst Blog Highlights Wells Fargo, Abbott Laboratories, American Express, TSS and Maui Land & Pineapple - Yahoo Finance

Jul 24, 2025
pulisher
Jul 23, 2025

Abbott Laboratories (ABT): I Am Very Upset With Abbott,” Says Jim Cramer - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Top Stock Reports for Wells Fargo, Abbott & American Express - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Brianne Gardner's Top Picks: Abbott Labs, Chipotle Mexican Grill & Motorola Solutions - BNN Bloomberg

Jul 23, 2025
pulisher
Jul 23, 2025

Jim Cramer Says He “Was Discouraged to Get a Mixed Update from Abbott Labs” - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Institutional owners may ignore Abbott Laboratories' (NYSE:ABT) recent US$10b market cap decline as longer-term profits stay in the green - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Notable healthcare headlines for the week: Trump’s tariff threats, J&J, Abbott Laboratories and Sarepta in focus - MSN

Jul 23, 2025

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices BSX
$105.41
price up icon 0.47%
medical_devices SYK
$377.79
price down icon 3.80%
medical_devices MDT
$89.34
price down icon 1.00%
medical_devices EW
$79.33
price up icon 0.03%
$69.85
price down icon 2.06%
大文字化:     |  ボリューム (24 時間):